On 28 MAY Harvard Bioscience, Inc. (NASDAQ:HBIO) said it will present at the SeeThruEquity Third Annual Microcap Investor Conference in New York City. Harvard Bioscience, Inc. (NASDAQ:HBIO) net profit margin is -1.10% and weekly performance is -0.76%. On last trading day company shares ended up $3.93. Analysts mean target price for the company is $6.10. Harvard Bioscience, Inc. (NASDAQ:HBIO) distance from 50-day simple moving average (SMA50) is -5.08%.
On 24 JUNE IsoRay, Inc. (NYSEMKT: ISR) announced the treatment of a brain tumor that had metastasized from esophageal cancer utilizing IsoRay’s liquid Cesium-131. IsoRay, Inc. (NYSEMKT: ISR) shares advanced 5.69% in last trading session and ended the day on $3.16. ISR Gross Margin is 2.20% and its return on assets is -46.30%. IsoRay, Inc. (NYSEMKT: ISR) quarterly performance is 34.47%.
On 25 JUNE Arrowhead Research Corp (NASDAQ:ARWR) reported ($0.31) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.20) by $0.11. Analysts expect that Arrowhead Research Corp will post $-0.92 EPS for the current fiscal year. Arrowhead Research Corp (NASDAQ:ARWR) shares moved up 5.96% in last trading session and was closed at $14.22 , while trading in range of $13.39 – $14.28. Arrowhead Research Corp (NASDAQ:ARWR) year to date (YTD) performance is 31.06%.
On 12 JUNE Ruthigen Inc (NASDAQ:RTGN) announced regulatory approval to advance testing of a new antibiotic for surgery and wound care. Ruthigen Inc (NASDAQ:RTGN) ended the last trading day at $6.47. Company weekly volatility is calculated as 6.55%. Ruthigen Inc (NASDAQ:RTGN) showed a negative weekly performance of -2.12%.
Nature’s Sunshine Prod. (NASDAQ:NATR) said its gross profit margin is currently very high, coming in at 77.16%. It has increased from the same quarter the previous year. Along with this, the net profit margin of 10.09% is above that of the industry average. Nature’s Sunshine Prod. (NASDAQ:NATR) net profit margin is 6.00% and weekly performance is 4.83%. On last trading day company shares ended up $16.71. Analysts mean target price for the company is $19.50. Nature’s Sunshine Prod. (NASDAQ:NATR) distance from 50-day simple moving average (SMA50) is 17.07%.